SCHEMBL812286

SCHEMBL812286

Cc1cc(-c2ccc(Cl)cc2)cc(C)c1C1=C(OC(=O)CC(C)C)CC(C)(C)CC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.39
ALPL P05186 1/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
POLB P06746 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 2/20 0.33
HPGD P15428 1/20 0.33
WRN Q14191 1/20 0.33
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
USP2 O75604 1/20 0.32
PTK2B Q14289 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HSD17B10 Q99714 1/20 0.32
OPRM1 P35372 2/20 0.32
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811968 0.85 LMNA (0.47) LMNAALPLKMT2AMAPTHPGD
SCHEMBL811966 0.79 LMNA (0.33) LMNAKMT2ASMN1; SMN2POLBNPC1
SCHEMBL823017 0.77 KMT2A (0.34) LMNAKMT2ASMN1; SMN2POLBNPC1
SCHEMBL812275 0.76 ALDH1A1 (0.47) LMNAALPLKMT2ASMN1; SMN2MAPT
SCHEMBL812270 0.73 NPC1 (0.32) LMNAKMT2ASMN1; SMN2POLBNPC1
SCHEMBL10946923 0.71 KMT2A (0.46) LMNAALPLKMT2ASMN1; SMN2MAPT
SCHEMBL10947059 0.69 ALDH1A1 (0.35) LMNAKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL10943778 0.67 TSHR (0.39) KMT2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL10945418 0.66 KMT2A (0.38) KMT2ASMN1; SMN2NPC1RAB9AHPGD
SCHEMBL811965 0.66 LMNA (0.37) LMNAALPLKMT2ASMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058210-B2 Arylphenyl-substituted cyclic keto-enols BAYER CROPSCIENCE AG (DE) 2011-11-15 US disclosed
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 US disclosed
US-7718706-B2 Arylphenyl-substituted cyclic keto-enols BAYER AKTIENGESELLSCHAFT (DE) 2010-05-18 US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 US disclosed
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS LIEB FOLKER 2010-04-08 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols LIEB FOLKER 2008-04-03 US disclosed
US-7288676-B2 Arylphenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-10-30 US disclosed
US-7288676-B2 Arylphenyl-substituted cyclic ketoenols BAYER CROPSCIENCE AG (DE) 2007-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081807-A1 Arylphenyl-substituted cyclic keto-enols KCNE1, DDT, KCNQ3 LMNA 2176/4885ALPL 3069/4885KMT2A 660/4885
US-20100087320-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO-ENOLS KCNE1, DDT, KCNQ3 LMNA 2176/4885ALPL 3069/4885KMT2A 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.